Taj Pharma India Limited - Company Profile

Q: Who are the current directors of Taj Pharma India Limited?

The current directors of Taj Pharma India Limited are Abhishek Ranvir Singh, Shantanu Kumar Singh, Priyanka Singh, Ranvir Kumar Bindeshwari Singh.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2011.

2011 Mumbai, Maharashtra, India Active

Last Updated: December 23, 2025

Access Report

About Taj Pharma India Limited

Taj Pharma India Limited, a active public limited company, was established on 28 June 2011 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33111MH2011PLC219226. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Abhishek Ranvir Singh (Director), Shantanu Kumar Singh (Director), Priyanka Singh (Additional Director). Past directors included Taiyebi Mohammed, Priyanka Singh, Sushma Singh. It holds ₹5.10 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 905, 9Th Floor, The Avenue Bldg, Marol Village, Navpada, Marol, Andheri E, Ast, Mumbai, Maharashtra, 400059.

Company Details

CIN/LLPIN
U33111MH2011PLC219226
Registration Number
219226
Incorporation Date
28 June 2011
Authorized Capital
₹0.50 M
Paid-Up Capital
₹0.50 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.50 M as on 23-12-2025
Paid Up Capital ₹ 0.50 M as on 23-12-2025
Company Age 14 Year, 7 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 5.10 Cr as on 23-12-2025
Revenue Growth **** 314.67% (FY 2024)
Profit Growth **** 127.12% (FY 2024)
Ebitda **** -69.66% (FY 2024)
Net Worth 25.06% (FY 2024)
Total Assets **** 50.47% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Taj Pharma India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Taj Pharma India Limited?

Current Directors

Name	Designation	Appointment Date	Status
Abhishek Ranvir Singh	Director	28 Jun 2011	Current
Shantanu Kumar Singh	Director	28 Jun 2011	Current
Priyanka Singh	Additional Director	27 Jul 2021	Current
Ranvir Kumar Bindeshwari Singh	Director	11 Dec 2012	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	29 Sep 2018	Past
Pramod Abcsdd	Director	05 Dec 2015	Past
Pramod Abcsdd	Director	11 Jan 2013	Past
Pramod Abcsdd	Additional Director	29 Sep 2018	Past
Pramod Abcsdd	Director	27 Jul 2012	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Taj Pharma India.

Taj Pharma India Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 314.67% increase. The company also saw a substantial improvement in profitability, with a 127.12% increase in profit. The company's net worth Soared by an impressive increase of 25.06%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

314.67%

*******

Revenue from Operations

*******

Total Assets

*******

50.47%

*******

Profit or Loss

*******

127.12%

*******

Net Worth

*******

25.06%

*******

EBITDA

*******

-69.66%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Taj Pharma India?

In 2024, Taj Pharma India had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹51,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Indian Overseas Bank : 5.10 Cr

Latest Charge Details

Date	Lender	Amount	Status
22 Sep 2022	Indian Overseas Bank	₹5.10 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Taj Pharma India?

Unlock and access historical data on people associated with Taj Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Taj Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Taj Pharma India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Taj Pharma India

Recent Activity within the Organization

Annual General Meeting

Taj Pharma India Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
30 Sep 2024
Balance Sheet

Progress on Taj Pharma India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
31 Mar 2024
Charges

A charge with Indian Overseas Bank amounted to Rs. 51.00 M with Charge ID 100623322 was registered on 22 Sep 2022. was recorded as a recent event.
22 Sep 2022
Director Appointment

The activity Priyanka Singh was appointed as a Additional Director was appointed as a Additional Director on 27 Jul 2021 & has been associated with this company since 4 years 6 months . was completed.
27 Jul 2021
Director Appointment

Ranvir Kumar Bindeshwari Singh was appointed as a Director was appointed as a Director on 11 Dec 2012 & has been associated with this company since 13 years 2 months . was recorded as a recent event.
11 Dec 2012
Director Appointment

Progress on Abhishek Ranvir Singh was appointed as a Director was appointed as a Director on 28 Jun 2011 & has been associated with this company since 14 years 7 months . was documented.
28 Jun 2011

Explore recent activity and updates - View Recent Activity